Skip to main content

Tecan to create Data-Driven Labs with NVIDIA

Written by Customer Service on . Posted in Public Companies.

Männedorf, Switzerland, March 17, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a strategic collaboration with NVIDIA focused on providing the AI-enabled platforms that Data-Driven Laboratories need to achieve faster discoveries and higher lab productivity.

Tecan pioneered the transition from manual pipetting to precise, robust, scalable automated pipetting in thousands of labs worldwide. Having led the first lab revolution Tecan continues to push lab automation by launching modern lab productivity products, such as Introspect, the lab analytics platform. Today, there is an exciting opportunity as a significant amount of the lab-generated data is not fully utilized.

Through the collaboration between NVIDIA and Tecan, the companies aim to ignite the next lab revolution, using AI and this yet unmapped data landscape to enable breakthrough discoveries and unprecedented productivity gains. Together, NVIDIA and Tecan are working to establish Data-Driven Labs.

Integrating NVIDIA GPU-accelerated models and libraries into Tecan’s products focuses on turning lab data into actions and impact. By linking scientific and operational data they target accelerating Tecan customers’ development of new treatments, as well as use physical AI to further scale up the usability and robustness of Tecan instruments.

«Artificial Intelligence is transformational but has yet to realize its full potential in the lab space and for the benefit of patients and science” said Monica Manotas, CEO of Tecan. “By pairing our lab footprint and expertise with NVIDIA’s state-of-the-art AI platforms and insights, we are uniquely positioned to help our customers address the growing need for higher lab productivity, faster discoveries, and intelligent automation solutions.»

The scope of this collaboration includes:

  • Agentic AI Introspect to increase Lab Productivity using NVIDIA Nemotron models and microservices
  • Discovery Introspect to support Faster Discoveries using NVIDIA CUDA-X libraries and NVIDIA Nemotron models
  • Physical AI to enable Next-Gen Lab Instrumentation integrating NVIDIA Cosmos open world foundation models and similar models

For more information about one of the use cases of this collaboration, please visit the Introspect landing page: Introspect™ custom web reports & dashboards – Tecan

About Tecan

Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,000 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2025, Tecan generated sales of CHF 883 million (USD 1,063 million; EUR 939 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.